Text Size

Supportive Therapy for Adherence to ART(STAART)

This study has been completed.
Sponsor:
Collaborator:
Ontario HIV Treatment Network
Information provided by:
Ottawa Hospital Research Institute
ClinicalTrials.gov Identifier:
NCT00212940
First received: September 13, 2005
Last updated: July 25, 2007
Last verified: July 2007
History of Changes
  Purpose

The purpose of this study is to determine whether a psycho-educational intervention can help people living with HIV handle the changes of treatment adherence.


Condition Intervention
HIV Infections
 Behavioral: Supportive Therapy for Adherence to ART (behavior)

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Official Title: Increasing Patient Adherence to HIV Medications: A Prospective Intervention Study

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by Ottawa Hospital Research Institute:

Primary Outcome Measures:
  • psycho-educational intervention can help people living with HIV handle the changes of treatment adherence

Estimated Enrollment: 112
Study Start Date: October 2000
Study Completion Date: September 2006
Detailed Description:

Participants will be randomly assigned to one of two study groups:

  • Group 1: participants in this group will engage in weekly psycho-educational sessions with an HIV therapist for four weeks prior to starting their regimens. The sessions will cover topics such as becoming active in treatment care, improving coping abilities and developing skills for treatment adherence. They will also involve questionnaires and readings.
  • Group 2 (the control group):participants in this group will simply receive their regular treatment regimens.
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • be at least 18 years of age
  • have viral load above 500 copies/ml
  • not be currently on HAART
  • be able to read and speak English/French

Exclusion Criteria:

  • current Substance Abuse
  • actively psychotic or suicidal
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00212940

Locations
Canada, Ontario
The Ottawa Hospital, General Campus
Ottawa, Ontario, Canada, K1H 8L6
Sponsors and Collaborators
Ottawa Hospital Research Institute
Ontario HIV Treatment Network
Investigators
Principal Investigator: William Cameron, MD OHRI
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00212940     History of Changes
Other Study ID Numbers: 1999565-01H, CIHR app# 1262000 ICE:
Study First Received: September 13, 2005
Last Updated: July 25, 2007
Health Authority: Canada: Health Canada

Keywords provided by Ottawa Hospital Research Institute:
Treatment Naive
HIV

Additional relevant MeSH terms:
HIV Infections
Acquired Immunodeficiency Syndrome
Lentivirus Infections
Retroviridae Infections
RNA Virus Infections
Virus Diseases
 Sexually Transmitted Diseases, Viral
Sexually Transmitted Diseases
Immunologic Deficiency Syndromes
Immune System Diseases
Slow Virus Diseases

ClinicalTrials.gov processed this record on May 22, 2013